2020
DOI: 10.21037/jtd-20-1855
|View full text |Cite
|
Sign up to set email alerts
|

A systematic review and meta-analysis of thoracoscopic versus thoracotomy sleeve lobectomy

Abstract: Background: Operative safety and oncologic adequacy of thoracoscopic sleeve lobectomy remain controversial. As such, the purpose of this meta-analysis was to evaluate evidence comparing thoracoscopy and thoracotomy in sleeve lobectomy for centrally located non-small cell lung cancer (NSCLC). Methods: Electronic searches of PubMed and Web of Science databases were undertaken from inception to March 2020. Comparative studies about thoracoscopic and thoracotomy sleeve lobectomy, with evaluation for perioperative … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
12
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 41 publications
1
12
0
2
Order By: Relevance
“…Since we only performed sleeve resection or bronchoplasty only by VATS, we were not able to compare the clinical outcomes from 3D VATS group and those from 2D VATS group. Our data revealed number of lymph nodes of 27.4 ± 13.2, operation time of 216.8 ± 60.0 minutes, hospital stay of median 6 days, and complication rate of 5.6%, which can be considered comparable from the previously reported excellent clinical outcomes from the 2D VATS sleeve lobectomy [ 31 , 32 ]. Uniportal VATS is gaining popularity these days but is reported to have some early difficulty and require a certain amount of learning curve because there is only one utility incision to share for the operator and the assistants [ 33 36 ].…”
Section: Discussionsupporting
confidence: 85%
See 1 more Smart Citation
“…Since we only performed sleeve resection or bronchoplasty only by VATS, we were not able to compare the clinical outcomes from 3D VATS group and those from 2D VATS group. Our data revealed number of lymph nodes of 27.4 ± 13.2, operation time of 216.8 ± 60.0 minutes, hospital stay of median 6 days, and complication rate of 5.6%, which can be considered comparable from the previously reported excellent clinical outcomes from the 2D VATS sleeve lobectomy [ 31 , 32 ]. Uniportal VATS is gaining popularity these days but is reported to have some early difficulty and require a certain amount of learning curve because there is only one utility incision to share for the operator and the assistants [ 33 36 ].…”
Section: Discussionsupporting
confidence: 85%
“…Regarding clinical outcomes from 2D VATS sleeve lobectomy versus sleeve lobectomy via thoracotomy, 2D VATS lobectomy revealed favorable clinical outcomes from many reports. Zhong et al reported from their systematic review and meta-analysis that 2D thoracoscopic sleeve lobectomy is a safe and efficient procedure with comparable clinical outcomes and oncologic results compared to thoracotomy sleeve lobectomy [ 31 ]. Deng et al reported from their recent meta-analysis that 2D VATS sleeve lobectomy yielded less surgical trauma than thoracotomy sleeve lobectomy and improved postoperative recovery without compromising oncological prognosis.…”
Section: Discussionmentioning
confidence: 99%
“…And as an echo of the "shift from pneumonectomy to lobectomy in the 50s", anatomical sleeve resection is a validated oncologic alternative not only to prevent the risk of residual tumor, but also to reduce post-operative mortality and to prevent a reduced QoL due to pneumonectomy [119][120][121][122][123]. Thoracotomy is the main approach for sleeve resection, but there is no absolute contraindication to using a minimally invasive approach as VATS or RATS, representing a validated oncologic and functional alternative to open sleeve lobectomy or pneumonectomy without compromising oncologic prognosis [124][125][126][127][128]. In a modern surgical era, these patients should also be proposed preoperative rehabilitation and ERAS protocols in order to reduce postoperative complications and to enhance recovery after surgery.…”
Section: Surgery For Ct4 Nsclcmentioning
confidence: 99%
“…Video-assisted thoracic surgery (VATS) was first used for the surgical treatment of non-small cell lung cancer (NSCLC) in the early 1990s. After more than 30 years of development, VATS has demonstrated outcomes comparable to thoracotomy and is now the treatment of choice for early-stage NSCLC (1).…”
Section: Introductionmentioning
confidence: 99%